Impel NeuroPharma is a startup based in the United States, 1 tracked investor.
Impel NeuroPharma is a startup based in the United States. Brouky records 1 investor associated with the company.
Impel NeuroPharma develops intranasal drug-delivery technologies designed to transport therapeutics to the central nervous system; its Precision Olfactory Delivery (POD) platform is focused on rapid delivery of treatments for migraine and other CNS disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.